Akorn, Inc. (NASDAQ: AKRX) today announced that the U.S. FDA has granted approval for Akorn's Abbreviated New Drug Application for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE